Core Viewpoint - Rani Therapeutics is actively engaging with investors through participation in two upcoming conferences in September 2024, showcasing its innovative oral delivery technology for biologics and drugs [1][2]. Group 1: Upcoming Conferences - Rani Therapeutics will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024, at 4:30 pm E.T. at the Lotte New York Palace Hotel, with CEO Talat Imran presenting [1]. - The company will also be featured at the 2024 Cantor Global Healthcare Conference on September 18, 2024, at 11:30 am E.T. at the InterContinental Barclay Hotel, again with CEO Talat Imran presenting [1]. - Both conferences will include formats such as company presentations, fireside chats, and one-on-one investor meetings, allowing for direct engagement with potential investors [1]. Group 2: Company Overview - Rani Therapeutics is a clinical-stage biotherapeutics company focused on the development of orally administered biologics and drugs, aiming to replace traditional subcutaneous injections and intravenous infusions [2]. - The company has developed the RaniPill® capsule, a proprietary and patented platform technology that has undergone several preclinical and clinical studies to assess its safety, tolerability, and bioavailability [2].
Rani Therapeutics to Participate in September Investor Conferences